Rachele Vaia

Verona, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Upper and lower airways response to tezepelumab in asthma patients with / without comorbid nasal polyposis: a 6-months reallife perspective.

Upper and lower airways response to tezepelumab in asthma patients with / without comorbid nasal polyposis: a 6-months reallife perspective.

Journal: Rhinology

Published: January 12, 2026

Upper and lower airways response to tezepelumab in asthma patients with / without comorbid nasal polyposis: a 6-months reallife perspective.

Upper and lower airways response to tezepelumab in asthma patients with / without comorbid nasal polyposis: a 6-months reallife perspective.

Journal: Rhinology

Published: January 12, 2026

Trends of T2 and Non-T2 Cytokines During Mepolizumab Treatment in Different Asthma Patient Subgroups.

Trends of T2 and Non-T2 Cytokines During Mepolizumab Treatment in Different Asthma Patient Subgroups.

Journal: Biomedicines

Published: December 31, 2025

Extracellular Vesicles in Asthma: Intercellular Cross-Talk in TH2 Inflammation.

Extracellular Vesicles in Asthma: Intercellular Cross-Talk in TH2 Inflammation.

Journal: Cells

Published: February 19, 2025

Profiling Blood Hypereosinophilia in Patients on Dupilumab Treatment for Respiratory Conditions: A Real-Life Snapshot.

Profiling Blood Hypereosinophilia in Patients on Dupilumab Treatment for Respiratory Conditions: A Real-Life Snapshot.

Journal: The journal of allergy and clinical immunology. In practice

Published: August 06, 2024

Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort.

Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort.

Journal: The World Allergy Organization journal

Published: May 03, 2024

Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective.

Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective.

Journal: Biomedicines

Published: December 30, 2023

Successful switching from mepolizumab to dupilumab in a patient with EGPA in remission phase and persistent nasal polyposis.

Successful switching from mepolizumab to dupilumab in a patient with EGPA in remission phase and persistent nasal polyposis.

Journal: Rheumatology (Oxford, England)

Published: August 29, 2023

Low-dose anti-IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance.

Low-dose anti-IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance.

Journal: Orphanet journal of rare diseases

Published: April 24, 2023

Hidden Comorbidities in Asthma: A Perspective for a Personalized Approach.

Hidden Comorbidities in Asthma: A Perspective for a Personalized Approach.

Journal: Journal of clinical medicine

Published: February 10, 2023

Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective.

Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective.

Journal: Journal of clinical medicine

Published: January 20, 2023

Relevance of Smoking Habit in Severe Asthma Patients: Evidence from the Severe Asthma Network in Italy (SANI) Registry.

Relevance of Smoking Habit in Severe Asthma Patients: Evidence from the Severe Asthma Network in Italy (SANI) Registry.

Journal: Journal of clinical medicine

Published: November 22, 2022

Showing 1-12 of 16

Last Updated: 09/26/2026